Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Helsingfors, Finland, 2015-10-13 10:30 CEST (GLOBE NEWSWIRE) -- STOCKMANN Oyj Abp, Börsmeddelande 13.10.2015 kl. 11.30 EET Stockmannkoncernens försäljning i september 2015 uppgick till 111,7...
-
Helsinki, Finland, 2015-10-13 10:30 CEST (GLOBE NEWSWIRE) -- STOCKMANN plc, Company Announcement 13.10.2015 at 11:30 EET The Stockmann Group's sales amounted to EUR 111.7 million in September...
-
Paris, le 12 octobre 2015 LVMH Moët Hennessy Louis Vuitton, leader mondial des produits de luxe, réalise sur les neuf premiers mois de 2015 des ventes de 25,3 milliards d'euros, en hausse de 18...
-
Paris, 12 October 2015 LVMH Moët Hennessy Louis Vuitton, the world's leading luxury products group, recorded an 18% increase in revenue, reaching €25.3 billion, for the first nine months of 2015....
-
- CATQ – Encochleated Atovaquone – Demonstrates Enhanced Efficacy and Tissue Targeting over Current Formulation - BEDMINSTER, N.J., Oct. 10, 2015 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings,...
-
NEW HAVEN, CT and SAN DIEGO, Oct. 9, 2015 (GLOBE NEWSWIRE) -- Melinta Therapeutics, a privately held company developing novel antibiotics to treat serious bacterial infections, today announced...
-
WATERTOWN, Mass., Oct. 7, 2015 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening...
-
MENLO PARK, Calif., Oct. 7, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
-
PARIS, Oct. 7, 2015 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene...
-
SOUTH SAN FRANCISCO, Calif., Oct. 7, 2015 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing novel protein...